National Comprehensive Cancer Network

About NCCN

Now Available! Recorded Presentations from the NCCN 19th Annual Conference: Advancing the Standard of Cancer Care™

Did you miss the NCCN 19th Annual Conference: Advancing the Standard of Cancer Care™ held March 13 – 15, 2014 in Hollywood, Florida?

Recorded activities designed to meet the educational needs of physicians, nurses, pharmacists, and other clinical professionals who manage patients with cancer are now available at education.nccn.org/ac2014.

The National Comprehensive Cancer Network® (NCCN®) Annual Conference attracts more than 1,500 registrants from across the United States and around the world, including oncologists (in both community and academic settings), oncology fellows, nurses, pharmacists, and other health care professionals involved in the care of patients with cancer. Respected opinion leaders present the latest cancer therapies and provide updates on selected NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®), the data upon which the NCCN Guidelines® are based, and quality initiatives in oncology. Topics change annually, but focus on the major cancers and supportive care areas. The NCCN Annual Conference also includes case study discussion forums with experts from NCCN Member Institutions and roundtable discussions featuring the foremost professionals from the academic, patient advocacy, government, payer, industry, and business realms of cancer care.

The activities listed below are approved for AMA PRA Category 1 Credit(s)™. Nursing and pharmacy (ACPE) credits may also be provided. Please refer to the complete accreditation information provided before the individual educational activity for more details.

 

Breast Cancer

 

Hematologic Malignancies

 

Skin Malignancies

 

Supporters:
Breast Cancer
Supported by educational grants from AstraZeneca; Eisai Inc.; Genentech; and Novartis Oncology.

Hematologic Malignancies
Supported by educational grants from Bristol-Myers Squibb; Millennium: The Takeda Oncology Company; Novartis Oncology; and Spectrum Pharmaceuticals, Inc.; and by a grant from Onyx Pharmaceuticals.

Skin Malignancies
Supported by educational grants from Genentech and Prometheus Laboratories, Inc..